Advanced
  Home Compare Reports

Comparison with Similar Reports

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), D...

Publisher:        MarketsandMarkets

# of Pages:        423

Rating: 

1 User License $4,950

Publication Date:  October, 2021

Price:       $4,950 / User License




1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION AND SCOPE 34
1.2.1 INCLUSIONS AND EXCLUSIONS 34
1.2.2 MARKETS COVERED 35
FIGURE 1 RESPIRATORY CARE DEVICES SEGMENTATION 35
FIGURE 2 RESPIRATORY CARE DEVICES MARKET, BY REGION 35
1.2.3 YEARS CONSIDERED FOR THE MARKET STUDY 36
1.3 CURRENCY 36
TABLE 1 THE ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY CONVERSIONS TO USD 36
1.4 STAKEHOLDERS 37
1.5 LIMITATIONS 37
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 3 RESEARCH DESIGN 39
2.1.1 SECONDARY RESEARCH 40
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY RESEARCH 41
FIGURE 4 PRIMARY SOURCES 41
2.1.2.1 Key data from primary sources 42
2.1.2.2 Key industry insights 43
TABLE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 44
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 44
2.2 MARKET SIZE ESTIMATION 45
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 45
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC 46
FIGURE 9 SUPPLY-SIDE ANALYSIS: RESPIRATORY CARE DEVICES MARKET (2020) 47
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE RESPIRATORY CARE DEVICES MARKET (2021–2026) 48
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 12 TOP-DOWN APPROACH 49
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 50
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 50
2.4 MARKET SHARE ASSUMPTIONS 51
FIGURE 14 ASSUMPTIONS FOR THE STUDY 51
2.5 RISK ASSESSMENT 52
TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET 52
3 EXECUTIVE SUMMARY 53
FIGURE 15 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 53
FIGURE 16 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2020 VS. 2026 (USD MILLION) 54
FIGURE 17 RESPIRATORY CARE DEVICES MARKET, DISEASE INDICATIONS,
2021 VS. 2026 (USD MILLION) 55
FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 56
FIGURE 19 GEOGRAPHIC SNAPSHOT: RESPIRATORY CARE DEVICES MARKET 57
4 PREMIUM INSIGHTS 58
4.1 RESPIRATORY CARE DEVICES MARKET: MARKET OVERVIEW 58
FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE MARKET GROWTH DURING THE FORECAST PERIOD 58
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, 2020 59
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE RESPIRATORY CARE DEVICES MARKET IN NORTH AMERICA IN 2020 59
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 22 CHINA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 60
4.4 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC MIX 60
FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RESPIRATORY CARE DEVICES MARKET DURING THE FORECAST PERIOD 60
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS 61
FIGURE 24 DEVELOPING MARKETS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
FIGURE 25 MARKET DYNAMICS: IMPACT ANALYSIS 62
5.2 MARKET DRIVERS 63
5.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES 63
5.2.1.1 Rapid growth in the global geriatric population 64
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 64
5.2.1.2 Urbanization and growing pollution levels 64
FIGURE 27 DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE (~EVERY YEAR) 65
5.2.1.3 High prevalence of tobacco smoking 65
TABLE 4 PREVALENCE AND DEATHS CAUSED DUE TO LIFESTYLE DISEASES 65
5.2.1.4 Changing lifestyles 65
5.2.2 INCREASING INCIDENCE RATE OF PRETERM BIRTHS 66
TABLE 5 THE 10 COUNTRIES WITH THE HIGHEST NUMBER OF PRETERM BIRTHS 66
TABLE 6 THE 10 COUNTRIES WITH THE HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS 67
5.2.3 OUTBREAK OF INFECTIOUS DISEASES AFFECTING THE RESPIRATORY SYSTEM 67
5.2.4 UNDERPENETRATED MARKETS IN SLEEP AND COPD 67
5.2.5 FOCUS ON IMPROVING PATIENT OUTCOMES 68
5.2.6 RISING R&D INVESTMENTS RESULTING IN TECHNOLOGICALLY ADVANCED DEVICES 68
TABLE 7 PRODUCT LAUNCHES 69
FIGURE 28 R&D EXPENDITURE (% OF TOTAL REVENUE) BY KEY PLAYERS (2020 VS 2019) 69
5.3 MARKET RESTRAINTS 69
5.3.1 UNFAVORABLE REIMBURSEMENT SCENARIO 69
5.3.2 AVAILABILITY OF LOW-COST PRODUCTS FROM LOCAL MANUFACTURERS 70
5.3.3 HIGH COST OF CPAP MACHINES 70
5.4 MARKET OPPORTUNITIES 71
5.4.1 GROWING DEMAND FOR HOME CARE THERAPEUTIC DEVICES 71
5.4.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS THE ASIA PACIFIC AND LATIN AMERICA 71
5.4.3 POINT-OF-CARE DIAGNOSTICS 72
5.4.4 GROWING AWARENESS ABOUT THE ILL-EFFECTS OF UNTREATED SLEEP APNEA 72
TABLE 8 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA 73
5.5 MARKET CHALLENGES 74
5.5.1 LOW AWARENESS AND A LARGE UNDERDIAGNOSED AND UNDERTREATED POPULATION 74
5.5.2 HARMFUL EFFECTS OF CERTAIN DEVICES ON NEONATES 74
5.5.3 LACK OF PATIENT COMPLIANCE 75
6 INDUSTRY INSIGHTS 76
6.1 INDUSTRY TRENDS 76
6.1.1 RISING DEMAND FOR ENHANCED COMPACT & PORTABLE DEVICES 76
6.1.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSIONS 76
6.1.3 GROWING DEMAND FOR MULTIMODAL VENTILATION 76
6.1.4 RISING ADOPTION OF NONINVASIVE VENTILATION 77
FIGURE 29 IMPACT ON PATIENT’S LIVES WITH THE INTRODUCTION OF INNOVATIVE SOLUTIONS FOR UNMET PATIENT NEEDS 77
FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS LOWERING THE OVERALL COSTS FOR SLEEP APNEA TREATMENT 77
6.2 REGULATORY ANALYSIS 78
6.2.1 NORTH AMERICA 78
6.2.1.1 US 78
TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT 78
TABLE 10 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 78
6.2.1.2 Canada 79
TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 79
6.2.1.3 Europe 79
TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 80
6.2.1.4 Asia Pacific 80
6.2.1.4.1 Japan 80
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 81
6.2.1.4.2 China 81
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 81
6.2.1.4.3 India 82
6.3 ECOSYSTEM ANALYSIS 82
FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS 83
6.4 VALUE CHAIN ANALYSIS 83
FIGURE 32 VALUE CHAIN: RESPIRATORY CARE DEVICES MARKET 84
6.5 COVID-19 IMPACT ON THE RESPIRATORY CARE DEVICES MARKET 84
6.6 TECHNOLOGY TRENDS 85
6.6.1 E-NOSE TECHNOLOGY 85
6.6.2 MEMS TECHNOLOGY 85
6.6.3 ELECTROCHEMICAL TECHNOLOGY 85
6.6.4 WIRELESS GAS SENSOR TECHNOLOGY 85
6.7 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET 86
6.7.1 INTRODUCTION 86
6.7.2 THE FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE 86
6.7.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT 87
6.7.4 COVID-19 TO DRIVE THE DEMAND FOR ARTIFICIAL INTELLIGENCE IN VENTILATORS 87
6.8 SENSOR TECHNOLOGIES IN VENTILATORS 88
6.8.1 INTRODUCTION 88
6.8.2 FLOW SENSORS 88
6.8.3 OXYGEN SENSORS 89
6.8.4 PRESSURE SENSORS 89
6.9 PATENT ANALYSIS 90
6.9.1 PATENT PUBLICATION TRENDS 90
FIGURE 33 PATENT PUBLICATION TRENDS: 2010 TO 2021 90
6.9.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR RESPIRATORY CARE DEVICE PATENTS 91
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICE PATENTS 91
FIGURE 34 JURISDICTION ANALYSIS FOR THE US (2014-2021) 91
6.10 TRADE ANALYSIS 91
TABLE 16 TOP EXPORTERS OF MEDICAL VENTILATORS; CPAP; BIPAP; OXYGEN CONCENTRATORS, 2018 (IN USD MN) 92
TABLE 17 INDIA THERAPEUTIC RESPIRATION APPARATUS; OZONE, OXYGEN, AEROSOL THERAPY APPARATUS; ARTIFICIAL RESPIRATION OR OTHER THERAPEUTIC RESPIRATION APPARATUS EXPORTS BY COUNTRY, 2019 (IN 000’) 92
6.11 YC-YCC SHIFT: RESPIRATORY CARE DEVICES MARKET 93
FIGURE 35 YC-YCC SHIFT IN THE RESPIRATORY CARE DEVICES MARKET 93
6.12 CASE STUDIES 94
TABLE 18 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES 94
TABLE 19 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES AND SPIROMETERS 94
6.13 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 20 PORTER’S FIVE FORCES ANALYSIS 95
6.13.1 THREAT OF NEW ENTRANTS 95
6.13.2 THREAT OF SUBSTITUTES 96
6.13.3 BARGAINING POWER OF MANUFACTURERS 96
6.13.4 BARGAINING POWER OF BUYERS 96
6.13.5 INTENSITY OF COMPETITIVE RIVALRY 96
7 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT 97
7.1 INTRODUCTION 98
TABLE 21 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 98
TABLE 22 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
7.2 THERAPEUTIC RESPIRATORY CARE DEVICES 99
TABLE 23 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 24 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
7.2.1 PAP DEVICES 101
TABLE 25 PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 101
TABLE 26 PAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
7.2.1.1 CPAP devices 102
7.2.1.1.1 Significantly effective in treating severe and moderate OSA 102
TABLE 27 CPAP DEVICES AVAILABLE IN THE MARKET 103
TABLE 28 CPAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
7.2.1.2 APAP devices 104
7.2.1.2.1 Sleep apnea patients who struggle to breathe out with a CPAP device find it easier to breathe using APAP devices 104
TABLE 29 APAP DEVICES AVAILABLE IN THE MARKET 104
TABLE 30 APAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
7.2.1.3 BiPAP devices 105
7.2.1.3.1 BiPAP machines have important capabilities in the treatment of COVID-19 105
TABLE 31 BIPAP DEVICES AVAILABLE IN THE MARKET 106
TABLE 32 BIPAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
7.2.2 VENTILATORS 106
TABLE 33 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 34 VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
7.2.2.1 ICU ventilators 108
TABLE 35 ICU VENTILATORS AVAILABLE IN THE MARKET 108
TABLE 36 ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 37 ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
7.2.2.1.1 High-end ventilators 110
7.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive the adoption of high-end ventilators in developing countries 110
TABLE 38 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.2.2.1.2 Mid-end ventilators 111
7.2.2.1.2.1 Mid-end ventilators are mainly used in large and medium-sized hospitals and ambulatory care settings 111
TABLE 39 MID-END VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
7.2.2.1.3 Basic ventilators 112
7.2.2.1.3.1 Basic ventilators are the most preferred for predetermined and long-term ventilation in long-term care centers, home care, and ambulatory care centers 112
TABLE 40 BASIC VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 113
7.2.2.2 Portable/transportable ventilators 113
7.2.2.2.1 The increasing demand for home care is driving the adoption of portable/transportable ventilators 113
TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS AVAILABLE IN THE MARKET 114
TABLE 42 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 115
7.2.3 NEBULIZERS 115
7.2.3.1 Nebulizers are more effective compared to oral dosages 115
TABLE 43 NEBULIZERS AVAILABLE IN THE MARKET 116
TABLE 44 NEBULIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
7.2.4 HUMIDIFIERS 118
TABLE 45 HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 46 HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
7.2.4.1 Heated humidifiers 119
7.2.4.1.1 Ease of control and customizability drives the market growth for heated humidifiers 119
TABLE 47 HEATED HUMIDIFIERS AVAILABLE IN THE MARKET 120
TABLE 48 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
7.2.4.2 Passover humidifiers 121
7.2.4.2.1 Passover humidifiers inhibit the customization of the amount of moisture delivered to patients 121
TABLE 49 PASSOVER HUMIDIFIERS AVAILABLE IN THE MARKET 121
TABLE 50 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
7.2.5 OXYGEN CONCENTRATORS 122
TABLE 51 OXYGEN CONCENTRATORS AVAILABLE IN THE MARKET 123
TABLE 52 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 53 OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.5.1 Fixed oxygen concentrators 124
7.2.5.1.1 Fixed oxygen concentrators are less expensive compared to portable oxygen concentrators 124
TABLE 54 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.2.5.2 Portable oxygen concentrators 125
7.2.5.2.1 Low weight and portability to drive the growth of this segment 125
TABLE 55 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
7.2.6 INHALERS 127
TABLE 56 INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 57 INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 128
7.2.6.1 Metered-dose inhalers (MDIs) 128
7.2.6.1.1 MDIs are the most widely adopted inhalers among patients 128
TABLE 58 METERED-DOSE INHALERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.2.6.2 Dry powder inhalers (DPIs) 129
7.2.6.2.1 Lower clinical efficiency and dose variations in DPIs to restrain the market growth 129
TABLE 59 DRY POWDER INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
7.2.7 REUSABLE RESUSCITATORS 130
7.2.7.1 Reusable resuscitators are economical and can be disassembled, cleaned, or reassembled as per convenience 130
TABLE 60 REUSABLE RESUSCITATORS OFFERED BY MAJOR PLAYERS 131
TABLE 61 REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 62 REUSABLE RESUSCITATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 132
TABLE 63 ADULT RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 64 INFANT/NEONATAL RESUSCITATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 134
7.2.8 NITRIC OXIDE DELIVERY UNITS 134
7.2.8.1 Strong focus on developing innovative and advanced nitric oxide delivery units to boost its adoption in the coming years 134
TABLE 65 NITRIC OXIDE DELIVERY UNITS OFFERED BY MAJOR PLAYERS 135
TABLE 66 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.2.9 OXYGEN HOODS 136
7.2.9.1 The growing prevalence and recurrence of chronic lung diseases is expected to support the market growth for oxygen hoods 136
TABLE 67 OXYGEN HOODS OFFERED BY MAJOR PLAYERS 136
TABLE 68 OXYGEN HOODS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.3 MONITORING DEVICES 137
TABLE 69 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 70 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
7.3.1 PULSE OXIMETERS 138
TABLE 71 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS 139
TABLE 72 PULSE OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 73 PULSE OXIMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 140
7.3.1.1 Pulse oximeter sensors 140
7.3.1.1.1 The use of disposable pulse oximeter sensors reduces the risk of cross-contamination and HAIs 140
TABLE 74 PULSE OXIMETER SENSORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
7.3.1.2 Pulse oximeter equipment 141
7.3.1.2.1 The rising adoption of pulse oximeter equipment in home care settings is projected to drive the market growth 141
TABLE 75 PULSE OXIMETER EQUIPMENT OFFERED BY MAJOR PLAYERS 142
TABLE 76 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
7.3.2 CAPNOGRAPHS 143
7.3.2.1 Extensive research in capnography has led to the development of advanced capnographs 143
TABLE 77 CAPNOGRAPHS OFFERED BY MAJOR PLAYERS 143
TABLE 78 CAPNOGRAPHS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 144
7.3.3 GAS ANALYZERS 144
7.3.3.1 Increasing demand for point-of-care testing to drive the demand for portable gas analyzers 144
TABLE 79 GAS ANALYZERS OFFERED BY MAJOR PLAYERS 145
TABLE 80 GAS ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
7.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 146
TABLE 81 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 82 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 146
7.4.1 SPIROMETERS 147
7.4.1.1 Rising technological advancements in this segment to increase the adoption of spirometers 147
TABLE 83 SPIROMETERS OFFERED BY MAJOR PLAYERS 147
TABLE 84 SPIROMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 148
7.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 148
7.4.2.1 Rising incidence of obstructive sleep apnea to drive the growth for PSG devices 148
TABLE 85 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 149
TABLE 86 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
7.4.3 PEAK FLOW METERS 150
7.4.3.1 Peak flow meters are not preferred in hospitals due to the high variability in measurements obtained from these devices 150
TABLE 87 PEAK FLOW METERS OFFERED BY VARIOUS PLAYERS 150
TABLE 88 PEAK FLOW METERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 151
7.4.4 OTHER DIAGNOSTIC DEVICES 151
TABLE 89 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
7.5 CONSUMABLES & ACCESSORIES 152
TABLE 90 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 91 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 153
7.5.1 MASKS 154
TABLE 92 MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 93 MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 155
7.5.1.1 Reusable masks 155
7.5.1.1.1 Rising ICU hospital admissions during the COVID-19 pandemic to drive the adoption of reusable masks 155
TABLE 94 REUSABLE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
7.5.1.2 Disposable masks 156
7.5.1.2.1 Increasing patient population for respiratory diseases to drive the growth of this segment 156
TABLE 95 DISPOSABLE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
7.5.2 DISPOSABLE RESUSCITATORS 157
7.5.2.1 Technologically advanced valves in resuscitators to drive the market growth during the forecast period 157
TABLE 96 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
7.5.3 TRACHEOSTOMY TUBES 158
7.5.3.1 Introduction of new and advanced products with ergonomic designs to drive the market growth 158
TABLE 97 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 159
7.5.4 BREATHING CIRCUITS 159
7.5.4.1 The outbreak of COVID-19 has driven the rising demand for breathing circuits 159
TABLE 98 BREATHING CIRCUITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 160
7.5.5 NASAL CANNULAE 160
7.5.5.1 Increasing focus on minimally invasive surgery techniques is expected to boost the demand for nasal cannulae 160
TABLE 99 NASAL CANNULAE MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 161
7.5.6 OTHER CONSUMABLES & ACCESSORIES 162
TABLE 100 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
8 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS 163
8.1 INTRODUCTION 164
TABLE 101 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2019–2026 (USD MILLION) 164
8.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 164
8.2.1 THE INCREASING PREVALENCE OF COPD DRIVES THE DEMAND FOR RESPIRATORY CARE DEVICES 164
TABLE 102 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY,
2019–2026 (USD MILLION) 165
8.3 SLEEP APNEA 165
8.3.1 RISING AWARENESS FOR SLEEP APNEA DIAGNOSIS TO DRIVE THE DEMAND FOR RESPIRATORY CARE DEVICES 165
TABLE 103 INCREASING PREVALENCE OF SLEEP APNEA TO RAISE AWARENESS FOR ITS DIAGNOSIS 166
TABLE 104 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2019–2026 (USD MILLION) 167
8.4 ASTHMA 168
8.4.1 INCREASING GLOBAL BURDEN OF ASTHMA TO SUPPORT THE MARKET GROWTH 168
TABLE 105 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY,
2019–2026 (USD MILLION) 169
8.5 INFECTIOUS DISEASES 169
8.5.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE THE MARKET GROWTH 169
TABLE 106 INCIDENCE OF TB (RATE PER 100,000 POPULATION) 170
TABLE 107 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 171
8.6 OTHER DISEASE INDICATIONS 171
TABLE 108 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 172
9 RESPIRATORY CARE DEVICES MARKET, BY END USER 173
9.1 INTRODUCTION 174
TABLE 109 RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 174
9.2 HOSPITALS 174
9.2.1 HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE RESPIRATORY CARE DEVICES MARKET DURING THE FORECAST PERIOD 174
TABLE 110 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 175
9.3 HOME CARE SETTINGS 176
9.3.1 RISING TECHNOLOGICAL ADVANCEMENTS HAVE LED TO THE DEVELOPMENT OF COMPACT & LIGHTWEIGHT DEVICES FOR HOME CARE 176
TABLE 111 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 177
 
9.4 AMBULATORY CARE CENTERS (ACCS) 177
9.4.1 GRADUAL SHIFT IN PATIENT PREFERENCES FOR ACCS OVER EXPENSIVE AND EXTENDED HOSPITAL STAYS 177
FIGURE 36 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005–2020) 178
TABLE 112 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 179
10 RESPIRATORY CARE DEVICES MARKET, BY REGION 180
10.1 INTRODUCTION 181
FIGURE 37 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT 181
TABLE 113 RESPIRATORY CARE DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 182
10.2 NORTH AMERICA 182
FIGURE 38 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 183
TABLE 114 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 183
TABLE 115 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 116 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 117 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 118 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 119 NORTH AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 120 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 121 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 122 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 123 NORTH AMERICA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 124 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 125 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 187
TABLE 126 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 127 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 128 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 129 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 188
TABLE 130 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 188
 
10.2.1 US 189
10.2.1.1 The US dominates the market in North America due to the high burden of asthma & COPD in the country 189
TABLE 131 US: KEY INDICATORS 189
TABLE 132 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 190
TABLE 133 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 134 US: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 135 US: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 136 US: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 137 US: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 138 US: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 139 US: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 140 US: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 141 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 142 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 193
TABLE 143 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 144 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 145 US: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 146 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 194
TABLE 147 US: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 194
10.2.2 CANADA 195
10.2.2.1 The increasing incidence of COPD is driving the adoption of respiratory care devices in Canada 195
TABLE 148 CANADA: COPD AND ASTHMA STATISTICS (2019 VS 2020) 195
FIGURE 39 CANADA: ASTHMA PREVALENCE, BY AGE GROUP, 2017 VS. 2018 196
TABLE 149 CANADA: KEY INDICATORS 196
TABLE 150 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 197
TABLE 151 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 152 CANADA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 153 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 154 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 155 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 156 CANADA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 157 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 158 CANADA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 159 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 160 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 200
TABLE 161 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 162 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 163 CANADA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 164 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE/ DISORDERS, 2019–2026 (USD MILLION) 201
TABLE 165 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 201
10.3 EUROPE 202
FIGURE 40 EUROPE: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 202
TABLE 166 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 203
TABLE 167 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 168 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 169 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 170 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 171 EUROPE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 172 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 173 EUROPE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 174 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 175 EUROPE: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 176 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 177 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 206
TABLE 178 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 179 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 180 EUROPE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 181 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 208
TABLE 182 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 208
10.3.1 GERMANY 208
10.3.1.1 Increasing healthcare expenditure and strengthening of the healthcare infrastructure in Germany to drive market growth 208
TABLE 183 GERMANY: KEY INDICATORS 209
TABLE 184 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 209
TABLE 185 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 186 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 187 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 188 GERMANY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 189 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 190 GERMANY: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 191 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 192 GERMANY: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 193 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 194 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 212
TABLE 195 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 196 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 197 GERMANY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 198 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 214
TABLE 199 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 214
10.3.2 FRANCE 214
10.3.2.1 The high burden of COPD is due to the increasing tobacco consumption in the country to support the market growth 214
TABLE 200 FRANCE: KEY INDICATORS 215
TABLE 201 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 215
TABLE 202 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 203 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 204 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 205 FRANCE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 206 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 207 FRANCE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 208 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 209 FRANCE: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 210 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 218
TABLE 211 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 218
TABLE 212 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 213 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 214 FRANCE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 215 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 220
TABLE 216 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 220
10.3.3 UK 220
10.3.3.1 The UK market has registered a favorable increase in healthcare expenditure, thus supporting the market growth 220
TABLE 217 UK: KEY INDICATORS 221
TABLE 218 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 221
TABLE 219 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 220 UK: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 221 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 222 UK: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 223 UK: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 224 UK: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 225 UK: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 226 UK: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 227 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 228 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 224
TABLE 229 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 225
TABLE 230 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 231 UK: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 232 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 226
TABLE 233 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 226

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127